Primary [qlco]
prophylaxis [inpr]
Venous Thromboembolism [patf]
Ambulatory [ftcn]
Patients [podg]
Receive [qlco]
Chemotherapy [topp]
Venous Thromboembolism [patf]
Often [tmco]
complicate [ftcn]
Clinical course [tmco]
Increased [qnco]
Chemotherapy [topp]
Safety [hcpp]
Efficacy [qlco]
Primary [qlco]
Cancer Patient [podg]
treated [topp]
Chemotherapy [topp]
Uncertain [idcn]
Update [tmco]
Published [ocac]
objectives [inpr]
Efficacy [qlco]
Safety [hcpp]
Primary [qlco]
Venous Thromboembolism [patf]
Ambulatory [ftcn]
Cancer Patient [podg]
Receive [qlco]
Chemotherapy [topp]
Compared [acty]
placebo [topp]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Issue [fndg]
Clinical Trials [resa]
Registries [inpr]
Selection Criteria [qlco]
Controlled [ftcn]
Trial [resa]
Oral [spco]
Anticoagulant [phsu]
intervention [hlca]
intervention [hlca]
placebo [topp]
Anticoagulants [phsu]
Data Collection [resa]
Extracted [topp]
methodology [inpr]
Quality [qlco]
Patients [podg]
interventions [hlca]
Including [ftcn]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Bleeding [patf]
Primary [qlco]
Effectiveness [qlco]
Safety [hcpp]
Main [qlco]
Identified [qlco]
Additional [ftcn]
Controlled [ftcn]
Trial [resa]
Patients [podg]
Update [tmco]
search [inpr]
SO [geoa]
Update [tmco]
considered [idcn]
Trial [resa]
Patients [podg]
Evaluate [ftcn]
Pharmacological [bmod]
interventions [hlca]
Performed [ftcn]
Patients [podg]
Advanced Cancer [neop]
Bias [idcn]
Large [qnco]
Trial [resa]
Patients [podg]
Risk Ratio [qnco]
reduction [npop]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
ultra [medd]
weight [orga]
Heparin [bacs, carb, phsu]
semuloparin [orch, phsu]
Relative [famg]
placebo [topp]
apparent [idcn]
Bleeding [patf]
Risk Ratio [qnco]
LMWH [carb, phsu]
Compared [acty]
Inactive [qlco]
Reduced [qlco]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Risk Ratio [qnco]
Heterogeneity [qlco]
Tau [inpr]
Bleeding [patf]
Events [evnt]
Risk Ratio [qnco]
Patients [podg]
Multiple Myeloma [neop]
LMWH [carb, phsu]
reduction [npop]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Compared [acty]
VITAMIN K/WARFARIN [patf]
Antagonist [ortf]
Risk Ratio [qnco]
LMWH [carb, phsu]
Aspirin [orch, phsu]
Not significant [fndg]
Statistically [ocdi]
Risk Ratio [qnco]
Bleeding [patf]
Observed [ftcn]
Patients [podg]
treated [topp]
LMWH [carb, phsu]
Warfarin [hops, orch, phsu]
treated [topp]
Aspirin [orch, phsu]
Study [mnob]
Evaluated [ftcn]
Unfractionated Heparin [bacs, carb, phsu]
Inactive [qlco]
Bleeding [patf]
Study [mnob]
Group [idcn]
Reporting [hlca]
Venous Thromboembolism [patf]
Compared [acty]
placebo [topp]
Warfarin [hops, orch, phsu]
Statistically [ocdi]
reduction [npop]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Risk Ratio [qnco]
Antithrombin [aapp, phsu]
Evaluated [ftcn]
Study [mnob]
Involving [ftcn]
paediatric [bmod]
Patients [podg]
Venous Thromboembolism [patf]
Bleeding [patf]
Compared [acty]
Inactive [qlco]
Oral [spco]
Factor Xa Inhibitor [phsu]
apixaban [phsu]
Evaluated [ftcn]
Phase II Study [resa]
Dose [qnco]
Finding [sosy]
Suggest [idcn]
promise [idcn]
Bleeding [patf]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Comparison [acty]
placebo [topp]
Authors [prog]
Conclusions [idcn]
Update [tmco]
confirmed [qlco]
Primary [qlco]
LMWH [carb, phsu]
Reduced [qlco]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Ambulatory [ftcn]
Cancer Patient [podg]
treated [topp]
Chemotherapy [topp]
Addition [ftcn]
ultra [medd]
weight [orga]
Heparin [bacs, carb, phsu]
semuloparin [orch, phsu]
Reduced [qlco]
Symptomatic [ftcn]
Venous Thromboembolism [patf]
Broad [spco]
Confidence Intervals [qnco]
estimates [qnco]
Bleeding [patf]
Suggest [idcn]
anticoagulation [topp]
Additional [ftcn]
Benefit [qnco]
Ratio [qnco]
Anticoagulants [phsu]
setting [ftcn]
Routine [qlco]
prophylaxis [inpr]
Ambulatory [ftcn]
Cancer Patient [podg]
Recommended [idcn]
Safety Issues [inpo]
Address [inpr]
